How long after initiating ADT/androgen blockade is it acceptable to start docetaxel in a patient with high burden, de-novo metastatic HSPC where you are recommending triplet therapy?
Answer from: Medical Oncologist at Academic Institution
In ARASENS, patients were allowed to enroll if they had received no more than 3 months of ADT prior to starting docetaxel +/- darolutamide. The biologic underpinnings suggest that the combination is most likely to be effective if given together. Therefore, I generally prefer to start the patient on ...
Comments
Medical Oncologist at Alvin & Lois Lapidus Cancer Institute Northwest Hospital Does Gleason score come into play when you decide ...
Medical Oncologist at Huntsman Cancer Institute - University of Utah Health Care Yes. Typically, I am looking for multiple features...
Does Gleason score come into play when you decide ...
Yes. Typically, I am looking for multiple features...